Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 811

1.

Genomic landscape of high-grade meningiomas.

Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y, Chevalier A, Ducar M, Thorner AR, van Hummelen P, Stemmer-Rachamimov A, Artyomov M, Al-Mefty O, Dunn GP, Santagata S, Dunn IF, Beroukhim R.

NPJ Genom Med. 2017;2. pii: 15. doi: 10.1038/s41525-017-0014-7. Epub 2017 Apr 26.

2.

Free ammonia offers algal crop protection from predators in dairy wastewater and ammonium-rich media.

Thomas PK, Dunn GP, Passero M, Feris KP.

Bioresour Technol. 2017 Jul 5;243:724-730. doi: 10.1016/j.biortech.2017.07.008. [Epub ahead of print]

PMID:
28711800
3.

Genomic profile of human meningioma cell lines.

Mei Y, Bi WL, Greenwald NF, Agar NY, Beroukhim R, Dunn GP, Dunn IF.

PLoS One. 2017 May 26;12(5):e0178322. doi: 10.1371/journal.pone.0178322. eCollection 2017.

4.

Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.

Johanns TM, Dunn GP.

Cancer J. 2017 Mar/Apr;23(2):125-130. doi: 10.1097/PPO.0000000000000247. Review.

PMID:
28410300
5.

Confounding in longitudinal studies in addiction treatment research.

Pierce M, Dunn G, Millar T.

Addict Res Theory. 2017 May 4;25(3):236-242. doi: 10.1080/16066359.2016.1247812. Epub 2016 Dec 22.

6.

Randomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT study).

Anderson IM, Blamire A, Branton T, Brigadoi S, Clark R, Downey D, Dunn G, Easton A, Elliott R, Elwell C, Hayden K, Holland F, Karim S, Lowe J, Loo C, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, McAllister-Williams RH.

Southampton (UK): NIHR Journals Library; 2017 Mar.

7.

Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.

Anderson IM, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Elwell C, Hayden K, Holland F, Karim S, Loo C, Lowe J, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, McAllister-Williams RH; Ketamine-ECT Study team.

Lancet Psychiatry. 2017 May;4(5):365-377. doi: 10.1016/S2215-0366(17)30077-9. Epub 2017 Mar 27.

8.

Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial.

Uppaluri R, Winkler AE, Lin T, Law JH, Haughey BH, Nussenbaum B, Paniello RC, Rich JT, Diaz JA, Michel LP, Wildes T, Dunn GP, Zolkind P, Kallogjeri D, Piccirillo JF, Dehdashti F, Siegel BA, Chernock RD, Lewis JS Jr, Adkins DR.

Clin Cancer Res. 2017 May 1;23(9):2186-2194. doi: 10.1158/1078-0432.CCR-16-1469. Epub 2016 Nov 9.

9.

Outbreak of Piv-3 in a Neonatal Intensive Care Unit in England.

Dunn GL, Tapson H, Davis J, Gobin M.

Pediatr Infect Dis J. 2017 Mar;36(3):344-345. doi: 10.1097/INF.0000000000001443.

PMID:
27918381
10.

Single-particle mapping of nonequilibrium nanocrystal transformations.

Ye X, Jones MR, Frechette LB, Chen Q, Powers AS, Ercius P, Dunn G, Rotskoff GM, Nguyen SC, Adiga VP, Zettl A, Rabani E, Geissler PL, Alivisatos AP.

Science. 2016 Nov 18;354(6314):874-877.

PMID:
27856905
11.

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.

Johanns TM, Miller CA, Dorward IG, Tsien C, Chang E, Perry A, Uppaluri R, Ferguson C, Schmidt RE, Dahiya S, Ansstas G, Mardis ER, Dunn GP.

Cancer Discov. 2016 Nov;6(11):1230-1236. Epub 2016 Sep 28.

PMID:
27683556
12.

Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach.

Johanns TM, Ward JP, Miller CA, Wilson C, Kobayashi DK, Bender D, Fu Y, Alexandrov A, Mardis ER, Artyomov MN, Schreiber RD, Dunn GP.

Cancer Immunol Res. 2016 Dec;4(12):1007-1015. Epub 2016 Oct 31.

PMID:
27799140
13.

Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1.

Law JM, Stark SC, Liu K, Liang NE, Hussain MM, Leiendecker M, Ito D, Verho O, Stern AM, Johnston SE, Zhang YL, Dunn GP, Shamji AF, Schreiber SL.

ACS Med Chem Lett. 2016 Aug 18;7(10):944-949. eCollection 2016 Oct 13.

PMID:
27774134
14.

Pathways through opiate use and offending: A systematic review.

Hayhurst KP, Pierce M, Hickman M, Seddon T, Dunn G, Keane J, Millar T.

Int J Drug Policy. 2017 Jan;39:1-13. doi: 10.1016/j.drugpo.2016.08.015. Epub 2016 Oct 19.

15.

Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma.

Zolkind P, Dunn GP, Lin T, Griffith M, Griffith OL, Uppaluri R.

Oral Oncol. 2017 Aug;71:169-176. doi: 10.1016/j.oraloncology.2016.09.010. Epub 2016 Oct 14.

PMID:
27751760
16.

Delayed presentation of Boerhaave's syndrome.

Atie M, Dunn G, Falk GL.

BMJ Case Rep. 2016 Oct 13;2016. pii: bcr2016217391. doi: 10.1136/bcr-2016-217391. No abstract available.

PMID:
27737871
17.

Electrostatically Driven Nanoballoon Actuator.

Barzegar HR, Yan A, Coh S, Gracia-Espino E, Dunn G, Wågberg T, Louie SG, Cohen ML, Zettl A.

Nano Lett. 2016 Nov 9;16(11):6787-6791. Epub 2016 Oct 7.

PMID:
27704855
18.

Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors.

Mei Y, Bi WL, Greenwald NF, Du Z, Agar NY, Kaiser UB, Woodmansee WW, Reardon DA, Freeman GJ, Fecci PE, Laws ER Jr, Santagata S, Dunn GP, Dunn IF.

Oncotarget. 2016 Nov 22;7(47):76565-76576. doi: 10.18632/oncotarget.12088.

19.

Gastrointestinal tract obstruction secondary to post-operative oedema: does dexamethasone administration help?

Atie M, Khoma O, Dunn G, Falk GL.

J Surg Case Rep. 2016 Aug 23;2016(8). pii: rjw139. doi: 10.1093/jscr/rjw139.

20.

National trends and local delivery in old age mental health services: towards an evidence base. A mixed-methodology study of the balance of care approach, community mental health teams and specialist mental health outreach to care homes.

Challis D, Tucker S, Wilberforce M, Brand C, Abendstern M, Stewart K, Jasper R, Harrington V, Verbeek H, Jolley D, Fernandez JL, Dunn G, Knapp M, Bowns I.

Southampton (UK): NIHR Journals Library; 2014 Sep.

Supplemental Content

Loading ...
Support Center